The rise of the COVID-19 pandemic has led to a surge of popularity for telemedicine services in various markets, including Southeast Asia.
In their insight, Bain & Company points out that as regular doctor visit becomes risky or even impossible, patients are turning to internet-based options for diagnosis and treatment.
In fact, even before the pandemic hit the region, telemedicine services such as HaloDoc in Indonesia was one of the most well-funded medtech startups in the country.
This opportunity was also one that SSIVIX LAB is looking into with their MyCLNQ mobile app.
The e27 team first got in touch with the startup when they take part in TOP100 APAC 2019. Ever since then, it has gone on to become an e27 Pro member.
Catching up with them, we learned some of the latest updates from the company.
Also Read: A guide for medtech startups: What is ICD 10 or 11?
Everything in one go
In offering their services to the users, SSIVIX LAB uses a one-stop approach with their platform by including a range of healthcare services from telemedicine, non-emergency medical transportation, medical caregiver, to medical product marketplace.
The company started out by offering booking services for GP consultations.
Like many other startups, its founding began with a personal challenge faced by its founders.
“In the current environment, where most of the healthcare services operate in either a traditional way or some extent of digitalisation, getting each service requires patients to visit a website, make a call, or download an app. Quite a hassle for end patient and community,” says SSIVIX LAB Director Naghma K.
“Neighbourhood clinics or GPs average waiting time is 30 to 45 minutes where the majority of them are not using any digital booking system,” he continues.
In promoting the use of their app, the startup also faced some other unique challenge. Many of GPs in Singapore are of the older generation, making them reluctant to try out new technology to improve their practices.
To tackle this, SSIVIX LAB allows GPs to use their booking platform for free, while the startup charges specialists and monetise from their other services instead.
Also Read: [Updated] These 4 medtech startups will help you bust health myths during COVID-19 crisis
The next step
So far, the company claimed to have secured more than 10,000 downloads and saved more than 40,000 minutes of waiting time for patients.
“Our aim is to save 90 per cent of waiting time using artificial intelligence in our system,” says SSIVIX LAB Director Anupama Jha.
The startup is also a Social Enterprise Member of raiSE Singapore.
The startup said that it is currently fundraising for its seed funding round and aiming to expand its services to new markets such as India, Indonesia, Malaysia, and Thailand.
—
Image Credit: SSIVIX LAB
.
The post How SSIVIX LAB aims to make a difference in time of global health crisis with a one-stop healthcare app appeared first on e27.